These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22365167)

  • 1. Role of bioimpedance vectorial analysis in cardio-renal syndromes.
    Aspromonte N; Cruz DN; Ronco C; Valle R
    Semin Nephrol; 2012 Jan; 32(1):93-9. PubMed ID: 22365167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the "5B" approach.
    Ronco C; Kaushik M; Valle R; Aspromonte N; Peacock WF
    Semin Nephrol; 2012 Jan; 32(1):129-41. PubMed ID: 22365171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid overload assessment and management in heart failure patients.
    Tuy T; Peacock WF
    Semin Nephrol; 2012 Jan; 32(1):112-20. PubMed ID: 22365169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease.
    Yilmaz Z; Yildirim Y; Oto F; Aydin FY; Aydin E; Kadiroglu AK; Yilmaz ME
    Ren Fail; 2014 May; 36(4):495-501. PubMed ID: 24456050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment.
    Chuasuwan A; Kellum JA
    Semin Nephrol; 2012 Jan; 32(1):31-9. PubMed ID: 22365160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment.
    Jois P; Mebazaa A
    Semin Nephrol; 2012 Jan; 32(1):26-30. PubMed ID: 22365159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target organ cross talk in cardiorenal syndrome: animal models.
    Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume overload and cardiorenal syndromes.
    Ronco C; Maisel A
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():Si-iv; quiz Svi. PubMed ID: 20653717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods.
    Jaffrin MY; Morel H
    Med Eng Phys; 2008 Dec; 30(10):1257-69. PubMed ID: 18676172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of biomarkers in the diagnosis and management of cardio-renal syndromes.
    Cruz DN; Fard A; Clementi A; Ronco C; Maisel A
    Semin Nephrol; 2012 Jan; 32(1):79-92. PubMed ID: 22365166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume control in peritoneal dialysis patients guided by bioimpedance spectroscopy assessment.
    Luo YJ; Lu XH; Woods F; Wang T
    Blood Purif; 2011; 31(4):296-302. PubMed ID: 21242684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction.
    Guazzi M; Gatto P; Giusti G; Pizzamiglio F; Previtali I; Vignati C; Arena R
    Int J Cardiol; 2013 Nov; 169(6):379-84. PubMed ID: 24182905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-renal syndrome type 4: epidemiology, pathophysiology and treatment.
    House AA
    Semin Nephrol; 2012 Jan; 32(1):40-8. PubMed ID: 22365161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
    Papakrivopoulou E; Lillywhite S; Davenport A
    Nephrol Dial Transplant; 2012 Jan; 27(1):396-401. PubMed ID: 21765049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond diuretics: management of volume overload in acute heart failure syndromes.
    Hill JA; Yancy CW; Abraham WT
    Am J Med; 2006 Dec; 119(12 Suppl 1):S37-44. PubMed ID: 17113399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydration status assessment by multi-frequency bioimpedance in patients with advanced chronic kidney disease.
    Caravaca F; Martínez del Viejo C; Villa J; Martínez Gallardo R; Ferreira F
    Nefrologia; 2011; 31(5):537-44. PubMed ID: 21959720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of Urotensin II activity can impact on the volume status in predialysis chronic kidney disease.
    Yilmaz B; Yilmaz A; Sari F; Sarikaya AM; Ellidag HY; Kucukseymen S; Ozpelit E
    Ren Fail; 2015 Apr; 37(3):476-81. PubMed ID: 25608453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain natriuretic peptide and impedance cardiography to assess volume status in peritoneal dialysis patients.
    Granja CA; Tailor PT; Gorban-Brennan N; Francis J; Bekui A; Finkelstein FO
    Adv Perit Dial; 2007; 23():155-60. PubMed ID: 17886624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure in patients with kidney disease.
    Tuegel C; Bansal N
    Heart; 2017 Dec; 103(23):1848-1853. PubMed ID: 28716974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.